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OBJECTIVES The purpose of this research was to evaluate right ventricular (RV) remodeling after six
months of cardiac resynchronization therapy (CRT).
BACKGROUND Cardiac resynchronization therapy is beneficial in patients with end-stage heart failure. The
effect of CRT on RV size is currently unknown. Accordingly, the effects of CRT on RV size,
severity of tricuspid regurgitation, and pulmonary artery pressure were evaluated.
METHODS Fifty-six consecutive patients with end-stage heart failure (52% ischemic cardiomyopathy),
left ventricular (LV) ejection fraction (EF) 35%, QRS duration 120 ms, and left bundle
branch block were included. Clinical parameters, LV volumes, LVEF, LV dyssynchrony, and
RV chamber size were assessed at baseline and after six months of CRT; LV dyssynchrony
was assessed using tissue Doppler imaging.
RESULTS Clinical parameters improved significantly; LV dyssynchrony was acutely reduced after CRT
and remained unchanged at six-month follow-up. Left ventricular EF improved signif-
icantly from 19  6% to 26  8% (p  0.001), and LV end-diastolic volume decreased
from 257  98 ml to 227  86 ml (p  0.001). Right ventricular annulus decreased
significantly from 37  9 mm to 32  10 mm, RV short-axis from 29  11 mm to 26  7
mm, and RV long-axis from 89  11 mm to 82  10 mm (all p  0.001). Left ventricular
and RV reverse remodeling were only observed in patients with substantial LV dyssynchrony
at baseline. Finally, significant reductions in severity of tricuspid regurgitation and pulmonary
artery pressure were observed.
CONCLUSIONS Cardiac resynchronization therapy results in significant reverse LV and RV remodeling after
six months of CRT in patients with LV dyssynchrony. Moreover, CRT leads to a reduction
of the severity of tricuspid regurgitation and a decrease in pulmonary artery pressure. (J Am


















bongestive heart failure is one of the leading causes of
orbidity and mortality in the Western world (1,2). A
elatively new treatment modality in patients with end-stage
eart failure and a wide QRS complex is cardiac resynchro-
ization therapy (CRT). Several large randomized trials
ave shown sustained clinical benefit from CRT (3–7).
atients experienced an improvement in heart failure symp-
oms, quality-of-life, and exercise capacity. Moreover, CRT
esults in a significant reduction of the number of hospital-
zations for decompensated heart failure, and recent trials
ndicate a positive effect of CRT on mortality (3–8).
Echocardiographic evaluation of patients undergoing
RT indicated that clinical improvement is caused by
esynchronization of dyssynchronous left ventricular (LV)
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005, accepted April 4, 2005.ontraction (9–12). The CRT-induced LV resynchroniza-
ion results in improved LV systolic function, a decrease in
itral regurgitation, and reverse LV remodeling (9–13).
urrently, no data are available regarding the effects of CRT
n right ventricular (RV) chamber size and the severity of
ricuspid regurgitation. Beneficial effects of CRT on the size
f the RV and on the severity of tricuspid regurgitation may
urther explain the mechanism of symptomatic benefit from
RT (14,15).
Accordingly, the objective of this study was to evaluate
V remodeling after six months of CRT using echocardi-
graphy. The effects of CRT on the severity of tricuspid
egurgitation and pulmonary artery pressure were also eval-
ated. Finally, the relation between LV dyssynchrony and
he effects of CRT on the RV was explored.
ETHODS
atients and study protocol. Fifty-six consecutive patients
ith severe heart failure, scheduled for implantation of a
iventricular pacemaker, were prospectively included in this
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December 20, 2005:2264–9 Right Ventricular Remodeling After CRTion criteria for CRT: left ventricular ejection fraction
LVEF) 35%, severe heart failure (New York Heart
ssociation [NYHA] functional class III or IV), and a QRS
uration 120 ms with left bundle branch block configu-
ation. Patients with a recent myocardial infarction (3
onths) or decompensated heart failure were excluded.
Before pacemaker implantation, clinical status and QRS
uration were assessed. Two-dimensional echocardiography
t rest was performed to calculate LV volumes and LVEF,
nd to assess RV chamber size. Next, tissue Doppler
maging (TDI) was performed to evaluate LV dyssyn-
hrony. Left ventricular dyssynchrony and QRS duration
ere reassessed on the day after implantation and at
ix-month follow-up. Clinical status, LV volumes, LVEF,
nd RV chamber size were also reassessed at six-month
ollow-up.
linical evaluation. Evaluation of clinical status included
ssessment of NYHA functional class, quality-of-life score
using the Minnesota quality-of-life questionnaire), and
-min hall-walk test. In all patients, QRS duration was
easured from the surface electrocardiogram (ECG) using
he widest QRS complex from the leads II, V1, and V6. The
CGs were recorded at a speed of 25 mm/s and were
valuated by two independent observers without knowledge
f the clinical status of the patient.
chocardiography. Resting echocardiography and TDI
ere performed at baseline, the day after implantation, and
t six-month follow-up. Patients were imaged in the left
Abbreviations and Acronyms
CRT  cardiac resynchronization therapy
LAX  long-axis
LV  left ventricle/ventricular
LVEF  left ventricular ejection fraction
NYHA  New York Heart Association
RV  right ventricle/ventricular
SAX  short-axis
TDI  tissue Doppler imaging
TV ANN  tricuspid valve annulusigure 1. Apical four-chamber two-dimensional echocardiogram. Schematic dis
ize. LAX  long-axis; SAX  short-axis; TV ANN  tricuspid valve annuluateral decubitus position using a commercially available
ystem (Vingmed System Seven, General Electric-
ingmed, Milwaukee, Wisconsin). Images were obtained
sing a 3.5-MHz transducer, at a depth of 16 cm in the
arasternal and apical views (standard long-axis [LAX] and
wo- and four-chamber images). Standard two-dimensional
nd color Doppler data, triggered to the QRS complex,
ere saved in cine loop format. Left ventricular volumes
end-systolic, end-diastolic) and LVEF were calculated
rom the conventional apical two- and four-chamber im-
ges, using the biplane Simpson’s technique (16).
SSESSMENT OF RV CHAMBER SIZE. Right ventricular end-
iastolic chamber size was assessed using three parameters
hat were described previously by Foale et al. (17,18). These
arameters were assessed from the apical four-chamber
iew, as schematically displayed in Figure 1. The first
arameter is the diameter of the tricuspid valve annulus (TV
NN), defined as the point of attachment of the septal and
osterior leaflets to the atrioventricular junction. The sec-
nd measurement is the maximum dimension of the middle
hird of the RV, parallel to the tricuspid annulus (RV
hort-axis [SAX]). The last measurement included the
ajor axis of the RV (RV LAX) and is defined as the
istance between the RV apex to the mid-point of the
ricuspid annulus.
Inter- and intraobserver agreement for assessment of RV
hamber size were 98% and 96% for TV ANN, 90 and 92%
or RV SAX, and 94% and 95% for RV LAX, respectively.
DI TO ASSESS LV DYSSYNCHRONY. In addition to the
onventional echocardiographic examination, TDI was per-
ormed to assess LV dyssynchrony. For TDI, color Doppler
rame rates varied between 80 and 115 frames/ s depending
n the sector width of the range of interest; pulse repetition
requencies were between 500 Hz and 1 KHz, resulting in
liasing velocities between 16 and 32 cm/s. Tissue Doppler
maging parameters were measured from color images of
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Right Ventricular Remodeling After CRT December 20, 2005:2264–9nalyzed using commercial software (Echopac 6.1, General
lectric-Vingmed).
To determine LV dyssynchrony, the sample volume was
laced in the basal portions of the septum and the LV lateral
all; peak systolic velocities and time-to-peak systolic ve-
ocities were obtained, and the delay in peak velocity
etween the septum and the LV lateral wall was calculated
s an indicator of LV dyssynchrony (referred to as the
eptal-to-lateral delay) (9,19,20). Interventricular dyssyn-
hrony was assessed by comparing the delay between peak
ystolic velocity of the RV free wall and the LV lateral wall
11).
Based on previous observations, a septal-to-lateral
elay 60 ms was considered to represent severe LV
yssynchrony (9). Inter- and intraobserver agreement for
ssessment of the septal-to-lateral delay were 90% and 96%,
espectively (21).
SSESSMENT OF MITRAL AND TRICUSPID REGURGITATION.
he severity of mitral and tricuspid regurgitation was
raded semiquantitatively from color-flow Doppler images.
or quantification of mitral and tricuspid regurgitation, the
pical four-chamber images were used. Mitral and tricuspid
egurgitation were classified as: mild  1 (jet area/atrial
rea 10%), moderate  2 (jet area/atrial area 10% to
0%), moderately severe  3 (jet area/atrial area 20% to
5%), and severe  4 (jet area/atrial area 45%) (22,23).
Continuous-wave Doppler examination was also per-
ormed to estimate pulmonary artery systolic pressure from
he transtricuspid maximal regurgitant flow velocity.
All echocardiographic measurements were obtained by
wo independent observers without knowledge of the clin-
cal status of the patient.
acemaker implantation. The LV pacing lead was in-
erted transvenously via the subclavian route. First, a coro-
ary sinus venogram was obtained during occlusion of the
oronary sinus using a balloon catheter. Next, the LV pacing
ead was inserted in the coronary sinus with the help of an
-F guiding catheter and positioned as far as possible in the
enous system, preferably in the (postero)lateral vein. The
ight atrial and RV leads were positioned conventionally.
hen a conventional indication for an internal defibrillator
xisted, a combined device was implanted. For each patient
he atrioventricular interval was adjusted to maximize the
itral inflow duration using pulsed-wave Doppler echocar-
iography. No adjustments were made to the V-V interval
uring the first six months of CRT.
Cardiac resynchronization therapy device and lead im-
lantation was successful in all patients without major
omplications (Contak TR or CD, Guidant Corp., Minne-
polis, Minnesota, and Insync III or CD, Medtronic Inc.,
inneapolis, Minnesota). Two types of LV leads were used
Easytrack 4512 to 80, Guidant Corp., or Attain-SD 4189,
edtronic Inc.).
tatistical analysis. Continuous data were expressed as
ean values  SD and compared with the two-tailed
v
etudent t test for paired and unpaired data when appropri-
te. Univariate analysis for categorical variables was per-
ormed using the chi-square test with Yates’ correction. For
ll tests a p value 0.05 was considered statistically
ignificant.
ESULTS
ifty-six consecutive patients were included in this study (44
en, age 64  11 years). Baseline patient characteristics are
ummarized in Table 1.
ollow-up after CRT. CLINICAL PARAMETERS AND LV
EMODELING. QRS duration at baseline was 176  30 ms
range 122 to 240 ms) and shortened to 149  23 ms (p 
.001, range 92 to 198 ms) immediately after implantation,
hich remained unchanged (153  22 ms, range 86 to 202
s) at six months after CRT.
At six-month follow-up, a significant improvement in
linical status was observed, in combination with an im-
rovement in LVEF and a significant LV reverse remodel-
ng (Table 2).
V DYSSYNCHRONY. The day after implantation of the
acemaker, TDI demonstrated a significant reduction in
eptal-to-lateral delay from 114  57 ms to 37  32 ms (p
0.001), indicating LV resynchronization. Resynchroni-
ation was maintained after six months of CRT, as evi-
enced by a septal-to-lateral delay of 40  36 ms (p 
.001 vs. baseline, p  NS vs. immediately after implanta-
ion). Mean interventricular (RV-LV) dyssynchrony at
aseline was 51 36 ms, which decreased significantly after
ix months of CRT to 37  27 ms (p  0.05).
able 1. Baseline Characteristics
Patient Characteristics
(n  56)









RS duration (ms) 176  30
hythm
Sinus rhythm 49 (87%)
Atrial fibrillation 7 (13%)
VEF (%) 19  6
VEDV (ml) 258  98
VESV (ml) 213  91
edication
Diuretics 46 (82%)
ACE inhibitors 52 (93%)
Beta-blockers 28 (50%)
Anticoagulants/aspirin 52 (93%)
CE  angiotensin-converting enzyme; LVEDV  left ventricular end-diastolic
olume; LVEF  left ventricular ejection fraction; LVESV  left ventricular
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December 20, 2005:2264–9 Right Ventricular Remodeling After CRTV REMODELING. In line with the reverse remodeling of
he LV, CRT also resulted in a significant reverse remod-
ling of the RV at six-month follow-up (Table 2). All three
arameters reflecting RV chamber size showed a significant
ecrease after six months of CRT. The TV ANN showed a
ignificant decrease from 37  9 mm to 32  10 mm (p 
.01), RV SAX decreased from 29  11 mm to 26  7 mm
p  0.001), and RV LAX showed a reduction from 89 
1 mm to 82  10 mm (p  0.001). Of note, RV reverse
emodeling did not occur immediately after CRT (e.g., the
V SAX was 29  11 mm before CRT and 30  10 mm
mmediately after CRT, p  NS).
Patients were subsequently divided into quartiles accord-
ng to the baseline values for each RV size parameter. Right
entricular reverse remodeling was most outspoken in pa-
ients with the largest RV dilation at baseline (Figs. 2A to
C). A significant reduction in TV ANN was demonstrated
n the third and fourth quartiles, whereas the patients with
maller TV ANN at baseline (first and second quartiles)
howed no significant reduction in size (Fig. 2A). Similarly,
V SAX and RV LAX showed a significant reduction after
ix months of CRT in patients with larger baseline values
Figs. 2B and 2C). Of note, 6 of 14 patients in the fourth
uartile had signs of right-sided heart failure.
Right ventricular reverse remodeling was associated with
significant reduction in tricuspid regurgitation from 1.8 
.8 to 1.3  1.0 (p  0.001; Table 2). Moreover, CRT also
esulted in a significant reduction of pulmonary artery
ressure from 40  12 mm Hg to 30  11 mm Hg (p 
.001).
everse remodeling versus LV dyssynchrony. Patients
ith severe baseline LV dyssynchrony were defined as
aving a septal-to-lateral delay 60 ms on TDI before
mplantation of the pacemaker. Accordingly, 44 (79%)
atients had significant LV dyssynchrony (mean septal-to-
able 2. Clinical and Echocardiographic Variables Before and






(n  56) p Value
YHA functional class 3.1  0.3 1.9  0.5 0.001
OL score 41  15 24  13 0.001
-MWT (m) 277  143 409  140 0.001
VEF (%) 19  6 26  8 0.001
VEDV (ml) 257  98 227  86 0.001
VESV (ml) 213  91 172  80 0.001
V chamber size
TV ANN (mm) 37  9 32  10 0.001
RV SAX (mm) 29  11 26  7 0.001
RV LAX (mm) 89  11 82  10 0.001
itral regurgitation (grade) 2.1  0.9 1.3  0.9 0.001
ricuspid regurgitation (grade) 1.8  0.8 1.3  1.0 0.001
ulmonary artery pressure
(mm Hg)
40  12 30  11 0.001
RT cardiac resynchronization therapy; LAX long-axis; QOL quality-of-life;
V  right ventricle; SAX  short-axis; TV ANN  tricuspid valve annulus;
-MWT  6-min walk test; other abbreviations as in Table 1.ateral delay 137  41 ms, with an immediate decrease to
d
b0  40 ms after CRT, p  0.001), and 12 (19%) patients
id not have substantial dyssynchrony on TDI (mean
eptal-to-lateral delay 41  27 ms, which remained un-
hanged after CRT, 38  25 ms, p  NS). Baseline
haracteristics were not statistically different between the
wo groups (Table 3).
The changes in LV volumes, LVEF, and RV diameters in
atients with and without LV dyssynchrony are summarized
n Table 4. Patients with severe LV dyssynchrony before
igure 2. (A) Tricuspid valve annulus (TV ANN) at baseline and after six
onths of cardiac resynchronization therapy (CRT). Patients are divided
nto quartiles according to baseline TV ANN. (B) Right ventricular (RV)
hort-axis (SAX) at baseline and after six months of CRT. Patients are
ivided into quartiles according to baseline RV SAX. (C) Right ventricular
ong-axis (LAX) at baseline and after six months of CRT. Patients are
ivided into quartiles according to baseline RV LAX. Open bars 
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Right Ventricular Remodeling After CRT December 20, 2005:2264–9mplantation showed reverse LV remodeling, whereas LV
olumes did not decrease significantly after six months of
RT in patients without LV dyssynchrony at baseline.
oreover, LVEF increased significantly after six months of
RT in the patients with LV dyssynchrony only. Similarly,
significant reduction in RV dimensions was observed only
n the patients with LV dyssynchrony at baseline.
Of note, in the patients with significant LV dyssynchrony
t baseline, 86% showed an improvement of at least one
YHA functional class after six months of CRT.
ISCUSSION
he main findings can be summarized as follows. In
atients with LV dyssynchrony, CRT induces not only LV
everse remodeling, but also a significant reverse remodeling
f the RV. This effect was most outspoken in patients with
evere RV dilatation at baseline.
At present, CRT is considered a major breakthrough in
he treatment of patients with moderate-to-severe heart
ailure and has been demonstrated to result in a sustained
mprovement in symptoms and LV systolic function (5,13).
imilar benefits were demonstrated in the current study.
espite the reproducible positive clinical results, the exact
echanism underlying the benefit of CRT is still not
ntirely clear but may be related to: 1) an improvement of
V systolic function; 2) reduction of mitral regurgitation;
nd 3) reverse remodeling of the LV. The presence of LV
yssynchrony appears mandatory for these effects to occur as
emonstrated in previous studies (9–11,13). In the present
tudy, LV dyssynchrony (assessed by TDI before CRT) was
ignificant with a septal-to-lateral delay of 114  57 ms. In
articular, 79% of patients exhibited significant LV dyssyn-
hrony (defined as a septal-to-lateral delay 60 ms), and
1% of patients did not show LV dyssynchrony. In the
atients with LV dyssynchrony, resynchronization was ob-
ained immediately after CRT, which persisted during
ix-month follow-up. A significant improvement in LVEF
able 3. Baseline Characteristics in Patients With (n  44) and






(n  12) p Val
ge (yrs) 64  12 65  8 NS
ender (M/F) 34/10 10/2 NS






RS duration (ms) 178  31 169  27 NS
-MWT (m) 270  126 303  139 NS
OL score 42  15 37  16 NS
eptal-to-lateral delay (ms) 137  41 41  27 —
bbreviations as in Table 2.as observed in the dyssynchronous patients with signifi- Aant reverse LV remodeling, in line with previous studies
9,11,12). However, these beneficial effects were not ob-
erved in the absence of dyssynchrony at baseline (Table 4),
onfirming previous observations (9,11).
No data were yet available regarding the effects of CRT
n RV function. Because CRT causes an improvement in
V function, reduces mitral regurgitation, and normalizes
eurohormonal status, it seems plausible that CRT may also
ave beneficial effects on pulmonary artery pressure, RV
unction, and RV dilation. In the current study, the effects
f CRT on RV size, tricuspid regurgitation, and pulmonary
rtery pressure were evaluated. Right ventricular chamber
ize was evaluated using three echocardiographic measure-
ents that were introduced previously by Foale et al.
17,18). This standardized echocardiographic approach for
he assessment of RV dimensions has been demonstrated to
dequately reflect RV size. The current results illustrate that
RT not only induced LV reverse remodeling, but also
esulted in a significant reverse remodeling of the RV. Of
nterest, the effect was most outspoken in patients with
ore severe RV dilation at baseline. Moreover, RV reverse
emodeling was associated with a reduction in the severity of
ricuspid regurgitation and a significant decrease in pulmo-
ary artery pressure. The precise mechanism underlying the
eneficial effects on the RV is unclear. Similar to LV reverse
emodeling, RV reverse remodeling was related to the
resence of LV dyssynchrony at baseline. Patients without
aseline LV dyssynchrony did not exhibit RV reverse
emodeling after six months of CRT (Table 4). Still, the
eduction in RV dimensions appears not related by an acute
ecovery in LV dyssynchrony. An acute reduction in septal-
o-lateral delay occurred after initiation of CRT (from 114
57 ms at baseline to 37  32 ms immediately after CRT,
able 4. LV Volumes, LV Ejection Fraction, and RV
imensions at Baseline and After Six Months of CRT in
atients With (n  44) and Without LV Dyssynchrony





LV dyssynchrony present 220  93 170  83 0.05
LV dyssynchrony absent 189  82 176  77 NS
VEDV (ml)
LV dyssynchrony present 265  100 229  88 0.05
LV dyssynchrony absent 232  90 223  82 NS
VEF (%)
LV dyssynchrony present 18  6 27  8 0.05
LV dyssynchrony absent 20  7 22  8 NS
V ANN (mm)
LV dyssynchrony present 37  8 32  6 0.05
LV dyssynchrony absent 38  9 34  8 NS
V SAX (mm)
LV dyssynchrony present 30  11 25  7 0.05
LV dyssynchrony absent 29  10 29  8 NS
V LAX (mm)
LV dyssynchrony present 90  10 82  9 0.05
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December 20, 2005:2264–9 Right Ventricular Remodeling After CRT 0.01), but this reduction was not accompanied by an
cute reduction in RV dimensions (the baseline RV SAX
as 29  11 mm as compared to 30  10 mm
mmediately after CRT). It thus appears that a more
oordinated motion of the interventricular septum after
RT was not responsible for the reduction in RV dimen-
ions. Possibly sustained improved LV performance has led
o a reduction in pulmonary artery pressure (observed in the
urrent study), resulting in an improved RV function (as
videnced also by a reduction in tricuspid regurgitation).
lthough improvement in RV size and function after CRT
ave been demonstrated in the current study, the inclusion
f a control group could potentially have contributed to a
etter understanding of the mechanism involved. Future
tudies are needed to further resolve these issues.
onclusions. The clinical benefit of CRT on improvement
n LV function was confirmed in the current study. The
enefit from CRT was related to the presence of LV
yssynchrony before CRT. In addition, this is the first study
o demonstrate reverse RV remodeling after CRT, which
as associated with a reduction in tricuspid regurgitation
nd a decrease in pulmonary artery pressure; reverse RV
emodeling was most outspoken in severely dilated RVs and
nly observed when LV dyssynchrony was present at base-
ine. These findings may lead to a better understanding of
he beneficial effects of CRT on cardiac function as RV
everse remodeling, decreased tricuspid regurgitation, and
educed pulmonary artery pressure are likely to contribute to
he symptomatic benefit from CRT in patients with drug-
efractory heart failure.
eprint requests and correspondence: Dr. Jeroen J. Bax, De-
artment of Cardiology, Leiden University Medical Center,
lbinusdreef 2, 2333 ZA Leiden, the Netherlands. E-mail:
bax@knoware.nl.
EFERENCES
1. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More
‘malignant’ than cancer? Five-year survival following a first admission
for heart failure. Eur J Heart Fail 2001;3:315–22.
2. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007–18.
3. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biven-
tricular pacing in patients with heart failure and intraventricular
conduction delay. N Engl J Med 2001;344:873–80.
4. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of
hemodynamically optimized cardiac resynchronization therapy in pa-tients with heart failure and ventricular conduction delay. J Am Coll
Cardiol 2002;39:2026–33.
5. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchroniza-
tion in chronic heart failure. N Engl J Med 2002;346:1845–53.
6. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization
therapy with or without an implantable defibrillator in advanced
chronic heart failure. N Engl J Med 2004;350:2140–50.
7. Molhoek SG, Bax JJ, van Erven L, et al. Effectiveness of resynchro-
nization therapy in patients with end-stage heart failure. Am J Cardiol
2002;90:379–83.
8. Braunschweig F, Linde C, Gadler F, Ryden L. Reduction of hospital
days by biventricular pacing. Eur J Heart Fail 2000;2:399–406.
9. Bax JJ, Marwick TH, Molhoek SG, et al. Left ventricular dyssyn-
chrony predicts benefit of cardiac resynchronization therapy in patients
with end-stage heart failure before pacemaker implantation. Am J
Cardiol 2003;92:1238–40.
0. Leclercq C, Kass DA. Retiming the failing heart: principles and
current clinical status of cardiac resynchronization. J Am Coll Cardiol
2002;39:194–201.
1. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardio-
graphic evidence of reverse remodeling and improved synchronicity by
simultaneously delaying regional contraction after biventricular pacing
therapy in heart failure. Circulation 2002;105:438–45.
2. Penicka M, Bartunek J, De Bruyne B, et al. Improvement of left
ventricular function after cardiac resynchronization therapy is pre-
dicted by tissue Doppler imaging echocardiography. Circulation 2004;
109:978–83.
3. St. John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac
resynchronization therapy on left ventricular size and function in
chronic heart failure. Circulation 2003;107:1985–90.
4. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hyper-
tension in chronic heart failure. The role of the endothelium in
pathophysiology and management. Circulation 2000;102:1718–23.
5. Oakley C. Importance of right ventricular function in congestive heart
failure. Am J Cardiol 1988:62:14A–9A.
6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for
quantification of the left ventricle by two-dimensional echocardiogra-
phy. J Am Soc Echocardiogr 1989;2:358–67.
7. Foale R, Nihoyannopoulos P, McKenna W, et al. Echocardiographic
measurement of the normal adult right ventricle. Br Heart J 1986;56:
33–44.
8. Feigenbaum H. Echocardiography. 5th edition. Baltimore, MD:
Lippincott, Williams and Wilkins, 1994:158–66.
9. Bax JJ, Molhoek SG, van Erven L, et al. Usefulness of myocardial
tissue Doppler echocardiography to evaluate left ventricular dyssyn-
chrony before and after biventricular pacing in patients with idiopathic
dilated cardiomyopathy. Am J Cardiol 2003;91:94–7.
0. Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic
evaluation of cardiac resynchronization therapy: ready for routine
clinical use? J Am Coll Cardiol 2004;44:1–9.
1. Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between
QRS duration and left ventricular dyssynchrony in patients with
end-stage heart failure. J Cardiovasc Electrophysiol 2004;15:544–9.
2. Thomas JD. How leaky is that mitral valve? Simplified Doppler
methods to measure regurgitant orifice area. Circulation 1997;95:
548 –50.
3. Fisher EA, Goldman ME. Simple, rapid method for quantification of
tricuspid regurgitation by two-dimensional echocardiography. Am J
Cardiol 1989;18:1375–8.
